Drug factory · FDA FEI 3010419177

Optimus Drugs Private Limited

Unit - I, Survey No. 239 and 240, Dothigudem Village, Pochampally Mandal, Yadadri-Bhuvanagiri (D), India

India: 1

Problems found, fixed voluntarily at FDA's last inspection, Dec 19, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2016: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Aminocaproic AcidMakes the active ingredient Seton Pharmaceuticals, LLC 13925-530, 13925-531

FDA inspection history

EndedResultProgramProblems noted
Dec 19, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
May 23, 2019No problems foundDrug Quality Assurance—
Mar 18, 2016Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.